(Q33388109)

English

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

scientific article

Statements

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia (English)
Marta Lisa Battista

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit